J9310 Rituximab - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Rituximab

Brand Name:

Rituxan

Strength:

100 mg

HCPCS:

J9310

SEER*Rx Category:

Immunotherapy

Major Drug Class:

Monoclonal Antibody

Minor Drug Class:

CD20

Oral (Y/N):

No

FDA Approval Year:

1997

FDA Discontinuation Year:

CMS Effective Date:

Jan. 1, 1999

CMS Discontinuation Date:

Status:

In Use